Relationships between pulmonary micro-rna and proteome profiles, systemic cytogenetic damage and lung tumors in cigarette smoke-exposed mice treated with chemopreventive agents

Carcinogenesis

Volumn 34, Issue 10, 2013, Pages 2322-2329

  Izzotti, Alberto ^a   Balansky, Roumen ^a,b   D'Agostini, Francesco ^a   Longobardi, Mariagrazia ^a   Cartiglia, Cristina ^a   La Maestra, Sebastiano ^a   Micale, Rosanna T ^a   Camoirano, Anna ^a   Ganchev, Gancho ^b   Iltcheva, Marietta ^b   Steele, Vernon E ^c   De Flora, Silvio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b National Oncology Center Bulgaria   (Bulgaria)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEXAROTENE; INOSITOL; MICRORNA; PIOGLITAZONE; PROTEOME; VORINOSTAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYTOGENETICS; HISTOPATHOLOGY; LUNG TUMOR; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING;

EID: 84885116572     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt178     Document Type: Article

References (40)

1. Balansky, R. et al. (2007) Potent carcinogenicity of cigarette smoke in mice exposed early in life. Carcinogenesis, 28, 2236-2243.
2. Balansky, R. et al. (2012) Differential carcinogenicity of cigarette smoke in mice exposed either transplacentally, early in life or in adulthood. Int. J. Cancer, 130, 1001-1010.
3. De Flora, S. et al. (2012) Genomic and post-genomic effects of cigarette smoke: mechanisms and implications for risk assessment and prevention strategies. Int. J. Cancer, 131, 2721-2723.
4. Balansky, R. et al. (2010) Prevention of cigarette smoke-induced lung tumors in mice by budesonide, phenethyl isothiocyanate, and N-acetylcysteine. Int. J. Cancer, 126, 1047-1054.
5. Balansky, R. et al. (2012) Inhibition of lung tumor development by berry extracts in mice exposed to cigarette smoke. Int. J. Cancer, 131, 1991-1997.
6. Balansky, R. et al. (2009) Prenatal N-acetylcysteine prevents cigarette smoke-induced lung cancer in neonatal mice. Carcinogenesis, 30, 1398-1401.
7. Balansky, R. et al. (2012) Transplacental antioxidants inhibit lung tumors in mice exposed to cigarette smoke after birth: a novel preventative strategy? Curr. Cancer Drug Targets, 12, 164-169.
8. Izzotti, A. et al. (2010) Chemoprevention of cigarette smoke-induced alterations of MicroRNA expression in rat lungs. Cancer Prev. Res. (Phila)., 3, 62-72.
9. Izzotti, A. et al. (2010) Modulation of microRNA expression by budesonide, phenethyl isothiocyanate and cigarette smoke in mouse liver and lung. Carcinogenesis, 31, 894-901.
10. Izzotti, A. et al. (2012) MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis. Mutat. Res. Rev, 751, 287-303.
11. De Flora, S. et al. (2012) Smoke-induced microRNA and related proteome alterations. Modulation by chemopreventive agents. Int. J. Cancer, 131, 2763-2773.
12. Ogawa, T. et al. (2005) Suberoylanilide hydroxamic acid enhances gap junctional intercellular communication via acetylation of histone containing connexin 43 gene locus. Cancer Res., 65, 9771-9778.
13. Marks, P.A. (2007) Discovery and development of SAHA as an anticancer agent. Oncogene, 26, 1351-1356.
14. Zieleniak, A. et al. (2008) Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma. Arch. Immunol. Ther. Exp. (Warsz)., 56, 331-345.
15. Wattenberg, L.W. et al. (2000) Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol. Carcinogenesis, 21, 179-182.
16. Izzotti, A. et al. (2009) Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J., 23, 806-812.
17. Izzotti, A. et al. (2009) Relationships of microRNA expression in mouse lung with age and exposure to cigarette smoke and light. FASEB J., 23, 3243-3250.
18. Izzotti, A. et al. (2011) Dose-responsiveness and persistence of microRNA expression alterations induced by cigarette smoke in mouse lung. Mutat. Res., 717, 9-16.
19. Peng, J. et al. (2013) Estrogen metabolism within the lung and its modulation by tobacco smoke. Carcinogenesis, 34, 909-915.
20. Casto, B.C. et al. (2011) Prevention of mouse lung tumors by combinations of chemopreventive agents using concurrent and sequential administration. Anticancer Res., 31, 3279-3284.
21. Tran, K. et al. (2013) The combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancer. Carcinogenesis, 34, 199-210.
22. Pereira, M.A. et al. (2006) Prevention of mouse lung tumors by targretin. Int. J. Cancer, 118, 2359-2362.
23. Wang, Y. et al. (2006) Organ-specific expression profiles of rat mammary gland, liver, and lung tissues treated with targretin, 9-cis retinoic acid, and 4-hydroxyphenylretinamide. Mol. Cancer Ther., 5, 1060-1072.
24. Wang, Y. et al. (2009) Preventive effects of bexarotene and budesonide in a genetically engineered mouse model of small cell lung cancer. Cancer Prev. Res. (Phila)., 2, 1059-1064.
25. Wang, Y. et al. (2010) Chemopreventive effects of pioglitazone on chemically induced lung carcinogenesis in mice. Mol. Cancer Ther., 9, 3074-3082.
26. Fu, H. et al. (2011) Chemoprevention of lung carcinogenesis by the combination of aerosolized budesonide and oral pioglitazone in A/J mice. Mol. Carcinog., 50, 913-921.
27. Li, M.Y. et al. (2012) Pioglitazone prevents smoking carcinogen-induced lung tumor development in mice. Curr. Cancer Drug Targets, 12, 597-606.
28. Li, H. et al. (2011) Activation of PPAR? in myeloid cells promotes lung cancer progression and metastasis. PLoS One, 6, e28133.
29. Wattenberg, L.W. (1999) Chemoprevention of pulmonary carcinogenesis by myo-inositol. Anticancer Res., 19, 3659-3661.
30. Hecht, S.S. et al. (2002) Inhibition of lung tumorigenesis in A/J mice by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-L-cysteine and myo-inositol, individually and in combination. Carcinogenesis, 23, 1455-1461.
31. Gunning, W.T. et al. (2000) Chemoprevention of vinyl carbamate-induced lung tumors in strain A mice. Exp. Lung Res., 26, 757-772.
32. Zhang, Z. et al. (2000) A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin. Cancer Res., 60, 901-907.
33. Witschi, H. (2000) Successful and not so successful chemoprevention of tobacco smoke-induced lung tumors. Exp. Lung Res., 26, 743-755.
34. La Maestra, S. et al. (2013) DNA damage in exfoliated cells and histopathological alterations in the urinary tract of mice exposed to cigarette smoke and treated with chemopreventive agents. Carcinogenesis, 34, 183-189.
35. Hardisty, J.F. et al. (2008) Histopathology of the urinary bladders of cynomolgus monkeys treated with PPAR agonists. Toxicol. Pathol., 36, 769-776.
36. Sato, K. et al. (2011) Suppressive effects of acid-forming diet against the tumorigenic potential of pioglitazone hydrochloride in the urinary bladder of male rats. Toxicol. Appl. Pharmacol., 251, 234-244.
37. Bosetti, C. et al. (2013) Cancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysis. Oncologist, 18, 148-156.
38. Ziouzenkova, O. et al. (2008) Retinoid metabolism and nuclear receptor responses: New insights into coordinated regulation of the PPAR-RXR complex. FEBS Lett., 582, 32-38.
39. Tachibana, K. et al. (2008) The role of PPARs in cancer. PPAR Res., 102737.
40. Bradley, M.O. et al. (1987) Relationships among cytotoxicity, lysosomal breakdown, chromosome aberrations, and DNA double-strand breaks. Mutat. Res., 189, 69-79.